112 related articles for article (PubMed ID: 7681005)
21. Effect of glutamate receptor antagonists on N-methyl-D-aspartate- and (S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced convulsant effects in mice and rats.
Bisaga A; Krzascik P; Jankowska E; Palejko W; Kostowski W; Danysz W
Eur J Pharmacol; 1993 Oct; 242(3):213-20. PubMed ID: 7506658
[TBL] [Abstract][Full Text] [Related]
22. NMDA receptor antagonists protect against seizures and wet-dog shakes induced by 4-aminopyridine.
Fragoso-Veloz J; Tapia R
Eur J Pharmacol; 1992 Oct; 221(2-3):275-80. PubMed ID: 1426006
[TBL] [Abstract][Full Text] [Related]
23. Isolation and characterization of histogranin, a natural peptide with NMDA receptor antagonist activity.
Lemaire S; Shukla VK; Rogers C; Ibrahim IH; Lapierre C; Parent P; Dumont M
Eur J Pharmacol; 1993 May; 245(3):247-56. PubMed ID: 8101490
[TBL] [Abstract][Full Text] [Related]
24. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization.
Pittaluga A; Raiteri M
J Pharmacol Exp Ther; 1992 Jan; 260(1):232-7. PubMed ID: 1370540
[TBL] [Abstract][Full Text] [Related]
25. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal.
Raiteri M; Garrone B; Pittaluga A
J Pharmacol Exp Ther; 1992 Jan; 260(1):238-42. PubMed ID: 1370541
[TBL] [Abstract][Full Text] [Related]
26. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Eur J Pharmacol; 1994 Sep; 262(1-2):11-9. PubMed ID: 7529182
[TBL] [Abstract][Full Text] [Related]
27. Comparative effects of felbamate and other compounds on N-methyl-D-aspartic acid-induced convulsions and lethality in mice.
Sofia RD; Gordon R; Gels M; Diamantis W
Pharmacol Res; 1994; 29(2):139-44. PubMed ID: 8058587
[TBL] [Abstract][Full Text] [Related]
28. Mg2+ antagonizes alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-induced brain damage and convulsions.
Fischer S; Wolf G; Keilhoff G; Hass P
Eur J Pharmacol; 1993 Feb; 232(1):121-4. PubMed ID: 7681405
[TBL] [Abstract][Full Text] [Related]
29. Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid.
Czuczwar SJ; Meldrum B
Eur J Pharmacol; 1982 Sep; 83(3-4):335-8. PubMed ID: 6293844
[TBL] [Abstract][Full Text] [Related]
30. Dynorphin potentiation of [3H]CGP-39653 binding to rat brain membranes.
Dumont M; Lemaire S
Eur J Pharmacol; 1994 Dec; 271(1):241-4. PubMed ID: 7698209
[TBL] [Abstract][Full Text] [Related]
31. NMDA antagonist properties of gamma-L-glutamyl-L-aspartate demonstrated on chemically induced seizures in mice.
Mathis C; De Barry J; Ungerer A
Eur J Pharmacol; 1990 Aug; 185(1):53-9. PubMed ID: 2146137
[TBL] [Abstract][Full Text] [Related]
32. Potent quinoxaline-spaced phosphono alpha-amino acids of the AP-6 type as competitive NMDA antagonists: synthesis and biological evaluation.
Baudy RB; Greenblatt LP; Jirkovsky IL; Conklin M; Russo RJ; Bramlett DR; Emrey TA; Simmonds JT; Kowal DM; Stein RP
J Med Chem; 1993 Feb; 36(3):331-42. PubMed ID: 8093907
[TBL] [Abstract][Full Text] [Related]
33. Occurrence of bicuculline-, NMDA- and kainic acid-induced seizures in prenatally methamphetamine-exposed adult male rats.
Slamberová R; Rokyta R
Naunyn Schmiedebergs Arch Pharmacol; 2005 Nov; 372(3):236-41. PubMed ID: 16247608
[TBL] [Abstract][Full Text] [Related]
34. Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology.
Verdoorn TA; Dingledine R
Mol Pharmacol; 1988 Sep; 34(3):298-307. PubMed ID: 2901662
[TBL] [Abstract][Full Text] [Related]
35. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotectant effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonist.
Schoepp DD; Ornstein PL; Salhoff CR; Leander JD
J Neural Transm Gen Sect; 1991; 85(2):131-43. PubMed ID: 1834088
[TBL] [Abstract][Full Text] [Related]
37. Possible involvement of NMDA receptor-mediated transmission in barbiturate physical dependence.
Rabbani M; Wright J; Butterworth AR; Zhou Q; Little HJ
Br J Pharmacol; 1994 Jan; 111(1):89-96. PubMed ID: 7912157
[TBL] [Abstract][Full Text] [Related]
38. Chlormethiazole anticonvulsive efficacy diminished by N-methyl-D-aspartate but not kainate in mice.
Pilip S; Urbanska EM; Czuczwar SJ; Kleinrok Z; Turski WA
Eur J Pharmacol; 1998 Mar; 345(3):257-60. PubMed ID: 9592024
[TBL] [Abstract][Full Text] [Related]
39. Localization of NMDA and AMPA receptors in rat barrel field.
Jaarsma D; Sebens JB; Korf J
Neurosci Lett; 1991 Dec; 133(2):233-6. PubMed ID: 1687759
[TBL] [Abstract][Full Text] [Related]
40. Lateral hypothalamic injections of glutamate, kainic acid, D,L-alpha-amino-3-hydroxy-5-methyl-isoxazole propionic acid or N-methyl-D-aspartic acid rapidly elicit intense transient eating in rats.
Stanley BG; Ha LH; Spears LC; Dee MG
Brain Res; 1993 Jun; 613(1):88-95. PubMed ID: 7688643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
